Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -53,088 | -39,783 | -11,083 | -5,598 | -16,703 |
| Depreciation Amortization | 497 | 384 | 264 | 136 | 589 |
| Accounts payable and accrued liabilities | 543 | 674 | 421 | 385 | N/A |
| Other Working Capital | -3,429 | -2,007 | -2 | 678 | 1,044 |
| Other Operating Activity | 23,232 | 19,936 | 724 | 351 | 110 |
| Operating Cash Flow | $-32,245 | $-20,796 | $-9,676 | $-4,048 | $-14,960 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -506 | -235 | -235 | -99 | -1,200 |
| Investing Cash Flow | $-506 | $-235 | $-235 | $-99 | $-1,200 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -4,568 | -4,568 | N/A | N/A | N/A |
| Common Stock Issued | 73,674 | 74,244 | 13 | 13 | N/A |
| Other Financing Activity | 8,040 | 8,040 | 6,154 | 7,738 | 72,682 |
| Financing Cash Flow | $77,146 | $77,716 | $6,167 | $7,751 | $72,682 |
| Beginning Cash Position | 73,058 | 73,058 | 73,058 | 73,058 | 16,536 |
| End Cash Position | 117,453 | 129,743 | 69,314 | 76,662 | 73,058 |
| Net Cash Flow | $44,395 | $56,685 | $-3,744 | $3,604 | $56,522 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,245 | -20,796 | -9,676 | -4,048 | -14,960 |
| Capital Expenditure | -506 | -235 | -235 | -99 | N/A |
| Free Cash Flow | -32,751 | -21,031 | -9,911 | -4,147 | -14,960 |